ICPR 2020

24 - 27 September

Please note - ICPR 2020 has been moved to the 24-27th of September 2020, and will happen online.

More information on this page.

This is the fourth edition of the Interdisciplinary Conference on Psychedelic Research.

ICPR 2020 is an academic conference focused on high quality scientific and scholarly research into psychedelics. Many academic disciplines have important contributions to make within the field of psychedelic studies. ICPR aims to bridge and connect these disciplines, and to facilitate a dialogue between the diverse academic fields and researchers involved in the study of psychedelics.


What to expect?

Featured prominently at ICPR will be the latest findings from clinical research into psychedelics as treatments for mental and other disorders. ICPR also features cutting edge brain imaging research, and the latest findings from psychopharmacology and neurobiology studies. The conference will dedicate ample time for studies from the humanities: anthropological research, ethnographies, social sciences studies, historical research, and philosophical questions. Further, the conference will facilitate in-depth discussions about (psycho)therapeutic frameworks, reflections on therapeutic modalities, and mechanisms of change.


ICPR will host lectures, panel discussions, poster presentations, and practically oriented workshops for therapists, researchers and clinicians.


CE / CME Credits

We have applied for Continuing Medical Education (CME) credits for psychiatrists, addiction doctors, (clinical) psychologists, GZ-psychologists, and psychotherapists with NVvP, FGzPT and VVGN.

More information here.


Focus areas

  • Clinical research and applications
  • Mental health and well-being
  • Neuroscience and consciousness research
  • Mainstreaming and medicalisation
  • Ritual, setting and placebo
  • Psychedelics and ecology
  • Cultural and ethical aspects

Critical Perspectives

ICPR stresses the importance of addressing biases and blind spots in psychedelics research, encouraging reflective and critical engagement.


We invite our speakers to contribute to a constructive discourse that considers ethical standards and research practices in light of their broader implications for society.

Inclusive

ICPR is a podium for a wide variety of ideas, disciplines, perspectives, localities, and individuals involved in psychedelic research. We support and amplify the voices of researchers whose social or economic circumstances put them at a disadvantage to attending this conference. To facilitate this, we will offer scholarships to researchers from countries who have limited means to join the conference but whose perspectives bring added value to ICPR.

CONFIRMED SPEAKERS

Janis Phelps
JANIS PHELPS

Training future psychedelic therapists

Peter Gasser
PETER GASSER

The development of psycholytic/psychedelic therapy

Michael Mithoefer
MICHAEL MITHOEFER

MDMA-assisted Psychotherapy for PTSD – Update and Observations from Clinical Trials

RICK DOBLIN

FDA and EMA Drug Development of MDMA-assisted Psychotherapy for PTSD, and Beyond

NEWSLETTER

STAY IN TOUCH

Be the first to learn about the ticket sale, speaker announcements and all things ICPR.